AMIX

Autonomix Medical, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website autonomix.com
Employees(FY) 1
ISIN US05330T2050

Performance

+14.29%

-72.71%

-72.37%

-83.93%

-96.45%

YTD

-96.45%

Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Advanced Technical Analysis

Technical Analysis of AMIX 2024-12-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 30 indicating a bearish outlook, while the Oscillators Score of 56 suggests a neutral stance, and the overall Technical Score of 43 reinforces a neutral sentiment. This combination implies that while there are some bearish signals, the market is not strongly negativ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of AMIX

Stock Rank

Recent News & Updates

2024-12-18 19:30
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality(Globenewswire)
2024-12-04 19:30
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025(Globenewswire)
2024-11-25 03:00
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option(Globenewswire)
2024-11-21 20:15
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering(Globenewswire)
2024-11-10 19:00
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update(Globenewswire)
2024-10-30 20:00
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction(Globenewswire)
2024-10-29 20:30
Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial(Globenewswire)
2024-10-27 20:00
Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial(Globenewswire)
2024-10-24 23:30
Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th(Globenewswire)
2024-10-21 20:30
Autonomix Announces Reverse Stock Split(Globenewswire)
2024-10-07 20:30
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC(Globenewswire)
2024-10-02 20:35
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer(Newsdirect)
2024-09-25 19:30
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment(Globenewswire)
2024-09-19 20:30
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum(Globenewswire)
2024-09-08 19:00
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients(Globenewswire)
2024-08-26 20:30
Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-20 20:30
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress(Globenewswire)
2024-08-12 20:00
Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones(Globenewswire)
2024-08-01 20:30
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment(Globenewswire)
2024-07-23 20:00
Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology(Globenewswire)
2024-07-21 21:05
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series(Globenewswire)
2024-07-17 20:30
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor What This Means Segment Covering Technology License Agreement(Globenewswire)
2024-07-15 20:25
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?(Investorplace)
2024-07-15 19:43
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-07-15 01:48
Why Is Autonomix Medical (AMIX) Stock Up 120% Today?(Investorplace)
2024-07-15 01:30
Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer(Yahoo Finance)
2024-07-14 20:00
Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.(Globenewswire)
2024-07-11 20:45
Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer(Newsdirect)
2024-07-10 21:00
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform(Globenewswire)
2024-07-02 21:00
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor What This Means Segment(Globenewswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.